There have been 50 recent insider transactions recorded for Kinnate Biopharma Inc. (KNTE), including 20 buys and 29 sells. Total insider buying was valued at $6.57M and total insider selling at $12.17M.
Notable insiders with recent activity include Orbimed Advisors Llc, Mitchell Dean J, Gordon Carl L. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — KNTE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-04-03 |
Orbimed Advisors Llc |
10 Percent Owner |
Return of Shares |
450,000 |
$2.59 |
$1.16M |
- |
| 2024-04-03 |
Mitchell Dean J |
Director |
Return of Shares |
25,000 |
$3.48 |
$87K |
- |
| 2024-04-03 |
Gordon Carl L |
10 Percent Owner |
Return of Shares |
25,000 |
$3.48 |
$87K |
- |
| 2024-04-03 |
Flaherty Keith T. |
Director |
Return of Shares |
25,000 |
$3.48 |
$87K |
- |
| 2024-04-03 |
Tananbaum James B. |
10 Percent Owner |
Return of Shares |
20,250 |
$8.38 |
$169.7K |
- |
| 2024-04-03 |
Smaldone Alsup Laurie |
Director |
Return of Shares |
25,000 |
$3.48 |
$87K |
- |
| 2024-04-03 |
Foresite Capital Management Iv, Llc |
10 Percent Owner |
Return of Shares |
520,711 |
$2.59 |
$1.35M |
- |
| 2024-04-03 |
Sabzevari Helen |
Director |
Return of Shares |
20,250 |
$8.38 |
$169.7K |
- |
| 2024-04-03 |
Meltz Mark A |
COO General Counsel Secretary |
Return of Shares |
215,000 |
$6.78 |
$1.46M |
- |
| 2024-04-03 |
Epperly Melissa B, |
Director |
Return of Shares |
20,250 |
$24.46 |
$495.32K |
- |
| 2024-04-03 |
Farzan Nima |
Chief Executive Officer |
Return of Shares |
750,000 |
$6.78 |
$5.09M |
- |
| 2024-04-03 |
Rome Michael E |
Director |
Return of Shares |
20,250 |
$8.38 |
$169.7K |
- |
| 2024-04-03 |
Krishnamohan Neha |
Chief Financial Officer |
Return of Shares |
215,000 |
$6.78 |
$1.46M |
- |
| 2024-04-03 |
Desimone Jill |
Director |
Return of Shares |
50,000 |
$5.21 |
$260.5K |
- |
| 2024-03-01 |
Meltz Mark A |
COO General Counsel Secretary |
Tax Withholding of RSU |
558 |
$2.59 |
$1.45K |
27,578 |
| 2024-03-01 |
Williams Richard Thomas |
Chief Medical Officer |
Tax Withholding of RSU |
558 |
$2.59 |
$1.45K |
67,588 |
| 2024-03-01 |
Krishnamohan Neha |
Chief Financial Officer |
Tax Withholding of RSU |
1,506 |
$2.59 |
$3.9K |
64,087 |
| 2023-12-01 |
Meltz Mark A |
COO General Counsel Secretary |
Tax Withholding of RSU |
541 |
$2.25 |
$1.22K |
28,136 |
| 2023-12-01 |
Williams Richard Thomas |
Chief Medical Officer |
Tax Withholding of RSU |
541 |
$2.25 |
$1.22K |
68,146 |
| 2023-12-01 |
Krishnamohan Neha |
Chief Financial Officer |
Tax Withholding of RSU |
1,459 |
$2.25 |
$3.28K |
65,593 |
| 2023-09-01 |
Meltz Mark A |
COO General Counsel Secretary |
Tax Withholding of RSU |
541 |
$2.35 |
$1.27K |
28,677 |
| 2023-09-01 |
Williams Richard Thomas |
Chief Medical Officer |
Tax Withholding of RSU |
541 |
$2.35 |
$1.27K |
68,687 |
| 2023-09-01 |
Krishnamohan Neha |
Chief Financial Officer |
Tax Withholding of RSU |
1,459 |
$2.35 |
$3.43K |
67,052 |
| 2023-06-12 |
Mitchell Dean J |
Director |
RSU Award |
25,000 |
$3.48 |
$87K |
25,000 |
| 2023-06-12 |
Gordon Carl L |
10 Percent Owner |
RSU Award |
25,000 |
$3.48 |
$87K |
25,000 |
| 2023-06-12 |
Flaherty Keith T. |
Director |
RSU Award |
25,000 |
$3.48 |
$87K |
25,000 |
| 2023-06-12 |
Smaldone Alsup Laurie |
Director |
RSU Award |
25,000 |
$3.48 |
$87K |
25,000 |
| 2023-06-12 |
Sabzevari Helen |
Director |
RSU Award |
25,000 |
$3.48 |
$87K |
25,000 |
| 2023-06-12 |
Epperly Melissa B, |
Director |
RSU Award |
25,000 |
$3.48 |
$87K |
25,000 |
| 2023-06-01 |
Meltz Mark A |
COO General Counsel Secretary |
Tax Withholding of RSU |
541 |
$4.30 |
$2.33K |
29,218 |
| 2023-06-01 |
Williams Richard Thomas |
Chief Medical Officer |
Tax Withholding of RSU |
541 |
$4.30 |
$2.33K |
69,228 |
| 2023-06-01 |
Krishnamohan Neha |
Chief Financial Officer |
Tax Withholding of RSU |
1,459 |
$4.30 |
$6.27K |
68,511 |
| 2023-05-08 |
Tananbaum James B. |
10 Percent Owner |
Informative Buy |
229,044 |
$2.80 |
$641.32K |
520,711 |
| 2023-05-08 |
Foresite Capital Management Iv, Llc |
10 Percent Owner |
Informative Buy |
229,044 |
$2.80 |
$641.32K |
520,711 |
| 2023-05-05 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Buy |
490,511 |
$2.82 |
$1.38M |
1,368,338 |
| 2023-05-05 |
Gordon Carl L |
10 Percent Owner |
Informative Buy |
490,511 |
$2.82 |
$1.38M |
1,368,338 |
| 2023-05-04 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Buy |
83,459 |
$2.75 |
$229.51K |
877,827 |
| 2023-05-04 |
Gordon Carl L |
10 Percent Owner |
Informative Buy |
83,459 |
$2.75 |
$229.51K |
877,827 |
| 2023-05-02 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Buy |
58,826 |
$2.67 |
$157.07K |
794,368 |
| 2023-05-02 |
Gordon Carl L |
10 Percent Owner |
Informative Buy |
58,826 |
$2.67 |
$157.07K |
794,368 |
| 2023-05-01 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Buy |
124,545 |
$2.62 |
$326.31K |
735,542 |
| 2023-05-01 |
Gordon Carl L |
10 Percent Owner |
Informative Buy |
124,545 |
$2.62 |
$326.31K |
735,542 |
| 2023-04-28 |
Orbimed Advisors Llc |
10 Percent Owner |
Informative Buy |
60,997 |
$2.55 |
$155.54K |
610,997 |
| 2023-04-28 |
Gordon Carl L |
10 Percent Owner |
Informative Buy |
60,997 |
$2.55 |
$155.54K |
610,997 |
| 2023-03-01 |
Meltz Mark A |
COO General Counsel Secretary |
Tax Withholding of RSU |
638 |
$5.21 |
$3.32K |
27,286 |
| 2023-03-01 |
Williams Richard Thomas |
Chief Medical Officer |
Tax Withholding of RSU |
638 |
$5.21 |
$3.32K |
67,295 |
| 2023-03-01 |
Krishnamohan Neha |
Chief Financial Officer |
Tax Withholding of RSU |
1,721 |
$5.21 |
$8.97K |
67,378 |
| 2023-03-01 |
Desimone Jill |
Director |
Unknown |
- |
- |
- |
- |
| 2023-03-01 |
Desimone Jill |
Director |
RSU Award |
50,000 |
$5.21 |
$260.5K |
50,000 |
| 2023-02-17 |
Gordon Carl L |
10 Percent Owner |
RSU Award |
550,000 |
- |
- |
550,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry